We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+0.64%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$650M
AUM Growth
-$107M
Cap. Flow
-$73.7M
Cap. Flow %
-11.34%
Top 10 Hldgs %
28.5%
Holding
529
New
249
Increased
8
Reduced
22
Closed
155

Top Buys

Rank Stock Value
1
BEAM icon
Beam Therapeutics
BEAM
+$25.6M
2
PSFE icon
Paysafe
PSFE
+$12.2M
3
VIEW
View, Inc. Class A Common Stock
VIEW
+$11.9M
4
OUST icon
Ouster
OUST
+$9.91M
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$8.09M

Top Sells

Rank Stock Value
1
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$53.1M
2
SGTX
Sigilon Therapeutics, Inc. Common Stock
SGTX
+$27M
3
QTRX icon
Quanterix
QTRX
+$20.3M
4
SPRU icon
Spruce Power Holding Corp
SPRU
+$14.9M
5
SNRHU
Senior Connect Acquisition Corp. I Unit
SNRHU
+$10.3M

Sector Composition

Rank Sector Weight
1 Healthcare 27.3%
2 Financials 11.86%
3 Technology 7.97%
4 Industrials 4.89%
5 Communication Services 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WHD icon
51
Cactus
WHD
$5.68B
$3.06M 0.47%
+100,000
New +$3.03M
CTLP
52
DELISTED
Cantaloupe
CTLP
$3.05M 0.47%
+260,000
New +$2.74M
ENPC
53
DELISTED
Executive Network Partnering Corporation
ENPC
$3.04M 0.47%
312,490
+125
+0% +$1.25K
BODI icon
54
The Beachbody Company
BODI
$74.8M
$3.04M 0.47%
+6,000
New +$3.38M
VRCA icon
55
Verrica Pharmaceuticals
VRCA
$91.7M
$3.03M 0.47%
+20,000
New +$2.77M
LVTX
56
DELISTED
LAVA Therapeutics
LVTX
$3.02M 0.46%
+265,000
New +$3.64M
XGN icon
57
Exagen
XGN
$161M
$3.01M 0.46%
+172,170
New +$3.07M
TMAC.U
58
DELISTED
The Music Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
TMAC.U
$2.99M 0.46%
+300,000
New +$3.09M
MYPS icon
59
PLAYSTUDIOS Inc
MYPS
$89M
$2.98M 0.46%
299,997
– –
REGI
60
DELISTED
Renewable Energy Group, Inc.
REGI
$2.97M 0.46%
+45,000
New +$3.86M
SFT
61
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$2.91M 0.45%
35,000
– –
AEVA
62
Aeva Technologies
AEVA
$1.68B
$2.9M 0.45%
+50,000
New +$3.89M
HGEN
63
DELISTED
HUMANIGEN, INC.
HGEN
$2.87M 0.44%
+150,000
New +$2.74M
CAE icon
64
CAE Inc. Common Shares
CAE
$8.66B
$2.85M 0.44%
+100,000
New +$2.66M
AMYT
65
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$2.79M 0.43%
200,000
– –
NAUT icon
66
Nautilus Biotechnolgy
NAUT
$112M
$2.76M 0.42%
200,000
– –
CERT icon
67
Certara
CERT
$1.23B
$2.73M 0.42%
100,000
+10,000
+11% +$333K
SPRU icon
68
Spruce Power Holding Corp
SPRU
$40.6M
$2.69M 0.41%
37,500
-112,500
-75% -$14.9M
SWTX
69
DELISTED
SpringWorks Therapeutics
SWTX
$2.58M 0.4%
+35,000
New +$2.74M
GMBTU
70
DELISTED
Pivotal Holdings Corp Unit
GMBTU
$2.52M 0.39%
+250,000
New +$2.65M
DSEY
71
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
$2.5M 0.38%
+170,000
New +$2.53M
HCAQ
72
DELISTED
HealthCor Catalio Acquisition Corp. Class A Ordinary Shares
HCAQ
$2.5M 0.38%
+250,000
New +$2.56M
TSPQ.U
73
DELISTED
TCW Special Purpose Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
TSPQ.U
$2.49M 0.38%
+250,000
New +$2.5M
DHHCU
74
DELISTED
DiamondHead Holdings Corp. Unit
DHHCU
$2.48M 0.38%
+250,000
New +$2.62M
OMEG
75
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$2.48M 0.38%
+250,000
New +$2.6M
1 2
3
4 5

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, Monashee Investment Management held 529 positions worth $650M, down 14% from $757M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Monashee Investment Management withdrew a net $73.7M in Q1 2021, closing 155 positions and reducing 22 holdings. Its most notable exit was Sigilon Therapeutics, Inc. Common Stock, an estimated $27M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 30% a quarter earlier, followed by Financials and Technology.

Against the trend, Monashee Investment Management opened a new position in Beam Therapeutics worth $21.5M.

  • Monashee Investment Management's largest Q1 2021 buy was Beam Therapeutics: 268,820 shares worth $21.5M.
  • Monashee Investment Management added most to View, Inc. Class A Common Stock in Q1 2021, an estimated $11.9M increase.
  • Monashee Investment Management's biggest Q1 2021 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $53.1M.
  • Monashee Investment Management fully exited Sigilon Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $27M.
  • Monashee Investment Management's ten largest holdings make up 28% of its $650M portfolio in Q1 2021.
  • Monashee Investment Management opened 249 new positions and closed 155 in Q1 2021.
  • Monashee Investment Management's portfolio value fell 14% quarter-over-quarter to $650M.

Based on Monashee Investment Management's 13F filing for Q1 2021, filed 14 May 2021.